Annual Drug Patent Expirations for BRUKINSA
Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
This drug has sixty-four patent family members in twenty-nine countries.
The generic ingredient in BRUKINSA is zanubrutinib. One supplier is listed for this compound. Additional details are available on the zanubrutinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
